Dr. Öğr. Üyesi Hüseyin Saffet Beköz

• Myelodysplastic Syndromes 2 publications
  Source: OpenAlex / PubMed MeSHView publications
• Leukemia, Myeloid, Acute 2 publications
• Multiple Myeloma 2 publications
• Lymphoma, Large B-Cell, Diffuse 2 publications
• Lymphoma, Non-Hodgkin 2 publications
• COVID-19 2 publications
• Hodgkin Disease 2 publications
• Gastrointestinal Diseases 2 publications
• Aspergillosis 2 publications

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: medipol.com.tr.

Experience

• 2005 - 2013Şişli Memorial Hastanesimedipol.com.tr

Education

• 2005Akdeniz Üniversitesi Tıp Fakültesi, İç Hastalıkları, Hematolojimedipol.com.tr
• 2000İstanbul Üniversitesi İstanbul Tıp Fakültesi, İç Hastalıklarımedipol.com.tr
• 1993Selçuk Üniversitesi, Tıp Fakültesimedipol.com.tr

• SpecialtyHaematologymedipol.com.trFrom source
• Department name at the sourceKemik İliği Merkezi (Erişkin)medipol.com.trFrom source
• InstitutionMedipol Mega Üniversite Hastanesimedipol.com.trFrom source
• Area of workMyelodysplastic SyndromesExtracted from 2 publications · Model version —From source
• Publications77 publicationsOpenAlexFrom source
• Languagesİngilizcemedipol.com.trFrom source
• ORCID0000-0003-1237-8281ORCIDFrom source
• Last synchronised4 November 2026 20:29https://medipol.com.tr/doktorlarimiz/doktor-ogretim-uyesi-huseyin-saffet-bekozmedipol.com.tr

1. Universal Use of Novel Oral Anticoagulant Prophylaxis in Myeloma Patients Undergoing IMiD-Based Therapy: Real-World Experience

   Journal of Clinical Medicine, 2026

   DOI 10.3390/jcm15020453 PMID 41598391 2 citations (Europe PMC) Open-access full textSource: OpenAlex

2. Temporal dynamics and predictors of carbapenem-resistant gram-negative bacteria in bloodstream infections in hematological patients

   BMC Infectious Diseases, 2026

   DOI 10.1186/s12879-026-13082-3 PMID 41820858 Open-access full textSource: OpenAlex

3. Venetoclax-based treatment in adult relapsed/refractory acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center real-world experience

   Journal of Health Sciences and Medicine, 2026

   DOI 10.32322/jhsm.1825832 Open-access full textSource: OpenAlex

4. Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report

   Turkish Journal of Hematology, 2026

   DOI 10.4274/tjh.galenos.2026.13284 PMID 41914439 Open-access full textSource: OpenAlex

5. Real-World Experience with Belinostat in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma

   Annals of Medical Research, 2026

   DOI 10.5455/annalsmedres.2025.07.193 Open-access full textSource: OpenAlex

6. A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen

   Journal of Clinical Medicine, 2026

   DOI 10.3390/jcm15145401 PMID 42513315 Open-access full textSource: OpenAlex

7. Enterovirus Encephalitis Developing After Treatment for Follicular Lymphoma: A Case Report

   SN Comprehensive Clinical Medicine, 2026

   DOI 10.1007/s42399-026-02560-z Source: OpenAlex

8. Real-World Effectiveness and Renal Safety of Foscarnet for CMV Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation

   Journal of Clinical Medicine, 2026

   DOI 10.3390/jcm15166365 PMID 42652768 1 citation (Europe PMC) Open-access full textSource: OpenAlex

9. Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology

   Journal of Clinical Medicine, 2026

   DOI 10.3390/jcm15166350 PMID 42652754 Open-access full textSource: OpenAlex

10. When high dose methotrexate stops working, a successful bridge to transplant with TEDDI-R in a case of secondary CNS lymphoma

    Annals of Hematology, 2025

    DOI 10.1007/s00277-025-06285-2 PMID 40016397 Open-access full textSource: OpenAlex